Cargando…
Impact of home monitoring program on interstage mortality after the Norwood procedure
OBJECTIVE: While early outcome after the Norwood operation for hypoplastic left heart syndrome has improved, interstage mortality until bidirectional cavopulmonary shunt (BCPS) remains a concern. Our aim was to institute a home monitoring program to (HMP) decrease interstage mortality. METHODS: Amon...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600023/ https://www.ncbi.nlm.nih.gov/pubmed/37900558 http://dx.doi.org/10.3389/fcvm.2023.1239477 |
_version_ | 1785125896499232768 |
---|---|
author | Staehler, Helena Schaeffer, Thibault Wasner, Johanna Lemmer, Julia Adam, Michel Burri, Melchior Hager, Alfred Ewert, Peter Hörer, Jürgen Ono, Masamichi Heinisch, Paul Philipp |
author_facet | Staehler, Helena Schaeffer, Thibault Wasner, Johanna Lemmer, Julia Adam, Michel Burri, Melchior Hager, Alfred Ewert, Peter Hörer, Jürgen Ono, Masamichi Heinisch, Paul Philipp |
author_sort | Staehler, Helena |
collection | PubMed |
description | OBJECTIVE: While early outcome after the Norwood operation for hypoplastic left heart syndrome has improved, interstage mortality until bidirectional cavopulmonary shunt (BCPS) remains a concern. Our aim was to institute a home monitoring program to (HMP) decrease interstage mortality. METHODS: Among 264 patients who survived Norwood procedure and were discharged before BCPS, 80 patients were included in the HMP and compared to the remaining 184 patients regarding interstage mortality. In patients with HMP, events during the interstage period were evaluated. RESULTS: Interstage mortality was 8% (n = 21), and was significantly lower in patients with HMP (2.5%, n = 2), compared to those without (10.3%, n = 19, p = 0.031). Patients with interstage mortality had significantly lower birth weight (p < 0.001) compared to those without. Lower birth weight (p < 0.001), extra corporeal membrane oxygenation support (p = 0.002), and lack of HMP (p = 0.048) were risk factors for interstage mortality. Most frequent event during home monitoring was low saturation (<70%) in 14 patients (18%), followed by infection in 6 (7.5%), stagnated weight gain in 5 (6.3%), hypoxic shock in 3 (3.8%) and arrhythmias in 2 (2.5%). An unexpected readmission was needed in 24 patients (30%). In those patients, age (p = 0.001) and weight at BCPS (p = 0.007) were significantly lower compared to those without readmission, but the survival after BCPS was comparable between the groups. CONCLUSIONS: Interstage HMP permits timely intervention and led to an important decrease in interstage mortality. One-third of the patients with home monitoring program needed re-admission and demonstrated the need for earlier stage 2 palliation. |
format | Online Article Text |
id | pubmed-10600023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106000232023-10-27 Impact of home monitoring program on interstage mortality after the Norwood procedure Staehler, Helena Schaeffer, Thibault Wasner, Johanna Lemmer, Julia Adam, Michel Burri, Melchior Hager, Alfred Ewert, Peter Hörer, Jürgen Ono, Masamichi Heinisch, Paul Philipp Front Cardiovasc Med Cardiovascular Medicine OBJECTIVE: While early outcome after the Norwood operation for hypoplastic left heart syndrome has improved, interstage mortality until bidirectional cavopulmonary shunt (BCPS) remains a concern. Our aim was to institute a home monitoring program to (HMP) decrease interstage mortality. METHODS: Among 264 patients who survived Norwood procedure and were discharged before BCPS, 80 patients were included in the HMP and compared to the remaining 184 patients regarding interstage mortality. In patients with HMP, events during the interstage period were evaluated. RESULTS: Interstage mortality was 8% (n = 21), and was significantly lower in patients with HMP (2.5%, n = 2), compared to those without (10.3%, n = 19, p = 0.031). Patients with interstage mortality had significantly lower birth weight (p < 0.001) compared to those without. Lower birth weight (p < 0.001), extra corporeal membrane oxygenation support (p = 0.002), and lack of HMP (p = 0.048) were risk factors for interstage mortality. Most frequent event during home monitoring was low saturation (<70%) in 14 patients (18%), followed by infection in 6 (7.5%), stagnated weight gain in 5 (6.3%), hypoxic shock in 3 (3.8%) and arrhythmias in 2 (2.5%). An unexpected readmission was needed in 24 patients (30%). In those patients, age (p = 0.001) and weight at BCPS (p = 0.007) were significantly lower compared to those without readmission, but the survival after BCPS was comparable between the groups. CONCLUSIONS: Interstage HMP permits timely intervention and led to an important decrease in interstage mortality. One-third of the patients with home monitoring program needed re-admission and demonstrated the need for earlier stage 2 palliation. Frontiers Media S.A. 2023-10-11 /pmc/articles/PMC10600023/ /pubmed/37900558 http://dx.doi.org/10.3389/fcvm.2023.1239477 Text en © 2023 Staehler, Schaeffer, Wasner, Lemmer, Adam, Burri, Hager, Ewert, Hörer, Ono and Heinisch. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Staehler, Helena Schaeffer, Thibault Wasner, Johanna Lemmer, Julia Adam, Michel Burri, Melchior Hager, Alfred Ewert, Peter Hörer, Jürgen Ono, Masamichi Heinisch, Paul Philipp Impact of home monitoring program on interstage mortality after the Norwood procedure |
title | Impact of home monitoring program on interstage mortality after the Norwood procedure |
title_full | Impact of home monitoring program on interstage mortality after the Norwood procedure |
title_fullStr | Impact of home monitoring program on interstage mortality after the Norwood procedure |
title_full_unstemmed | Impact of home monitoring program on interstage mortality after the Norwood procedure |
title_short | Impact of home monitoring program on interstage mortality after the Norwood procedure |
title_sort | impact of home monitoring program on interstage mortality after the norwood procedure |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600023/ https://www.ncbi.nlm.nih.gov/pubmed/37900558 http://dx.doi.org/10.3389/fcvm.2023.1239477 |
work_keys_str_mv | AT staehlerhelena impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT schaefferthibault impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT wasnerjohanna impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT lemmerjulia impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT adammichel impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT burrimelchior impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT hageralfred impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT ewertpeter impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT horerjurgen impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT onomasamichi impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure AT heinischpaulphilipp impactofhomemonitoringprogramoninterstagemortalityafterthenorwoodprocedure |